TITLE

Oral contraceptives and myocardial infarction

AUTHOR(S)
Hoey, John
PUB. DATE
April 2002
SOURCE
CMAJ: Canadian Medical Association Journal;4/2/2002, Vol. 166 Issue 7, p931
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on myocardial infarction (MI) in women and risk factors for MI from oral contraceptives. Marketing of oral contraceptives containing third-generation progestogens; Paper by Tanis and colleagues which involved a study of women who had been admitted to the hospital following MI in the Netherlands; Information on risks associated with pregnancies and abortions which should be given to women; Control and prevention of MI from oral contraceptives.
ACCESSION #
6455277

 

Related Articles

  • DOCUMENTED TRANSMURAL MYOCARDIAL INFARCTION IN A 21--YEAR--OLD WOMAN WITH NORMAL CORONARY ARTERIO GRAMS. Martin, Carroll M.; Kleid, Jack J. // Angiology;Jun1975, Vol. 26 Issue 6, p450 

    Examines the transmural myocardial infarction in a woman with normal coronary arteriograms. Association of oral contraceptives in acute myocardial infarction; Appearance of normal coronary arteries on arteriographic examination; Possibility of misinterpretation of the arteriograms.

  • Benefits and Risks of OCPs Beyond Contraception. Zepf, Bill // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2233 

    Focuses on the benefits and risks of oral contraceptive pills (OCP). Guidelines on the use of estrogen-progestin oral contraceptives for women; Association of high estrogen doses with myocardial infarction and ischemic stroke; Risk of venous thromboembolism in patients taking pills with progestins.

  • Acute Uterine Bleeding: Progestin vs. Combination Therapy. Walling, Anne D. // American Family Physician;2/1/2007, Vol. 75 Issue 3, p398 

    The article presents a study which compares the effectiveness of progestin and combination of oral contraceptives in the treatment of nongestational acute uterine bleeding. Before randomization, bleeding was 15.5 days in the progestin group and 8 days in the combination group. During the...

  • Long-Acting Injectable Progestin Contraception and Risk of Type 2 Diabetes in Latino Women With Prior Gestational Diabetes Mellitus. Xiang, Anny H.; Kawakubo, Miwa; Kjos, Siri L.; Buchanan, Thomas A. // Diabetes Care;Mar2006, Vol. 29 Issue 3, p613 

    OBJECTIVE -- To investigate the impact of a long-acting injectable progestin, depomedroxyprogesterone acetate (DMPA), compared with combination oral contraceptives (COCs) on the risk of diabetes in Latino women with prior gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS -- An...

  • Independent Nurse: Clinical - Contraindications to the COC. Gupta, Geetika // GP: General Practitioner;3/19/2010, p16 

    The article focuses on the contraindications of combined oral contraceptive (COC) pills. COCs are known to increase arterial and venous thrombosis risk but this varies with other factors including smoking, age, and obesity. The relative risk of acute myocardial infarction in COC pill users and...

  • Third-generation pills may elevate risk of venous thromboembolism, slightly lower heart attack risk. Hollander, D. // Family Planning Perspectives;May/Jun96, Vol. 28 Issue 3, p131 

    The article presents information on risks associated with current use of various types of combined oral contraceptives among women aged 16-44. According to the preliminary report of a multinational case-control study, oral contraceptive users who take pills containing the "third-generation"...

  • Progestin-only emergency contraception pill now available. Hayes, Gloria; Lucas, Beverly // Patient Care;9/30/1999, Vol. 33 Issue 15, p12 

    Reports on the approval granted by the United States Food and Drug Administration to Plan B, the first progestin-only pill (POP) regimen for postcoital contraception. Superiority of POP over the traditional Yuzpe method; Dosage required by the regimen; Side effects.

  • Is There an Increased Risk of Stroke Associated with Oral Contraceptives? Zeitoun, K.; Carr, B.R. // Drug Safety;Jun1999, Vol. 20 Issue 6, p467 

    In the last few years several studies were published about the relationship between oral contraceptive use, estrogen dose, different types of progestogens, cigarette smoking and the risk of stroke. There is a persistent association between the use of oral contraceptives containing more than...

  • Progestogens with Antiandrogenic Properties. Raudrant, D.; Rabe, T. // Drugs;2003, Vol. 63 Issue 5, p463 

    Chlormadinone acetate, cyproterone acetate and dienogest are potent, orally active progestogens, which have antiandrogenic instead of partial androgenic activity. They act mainly by blocking androgen receptors in target organs, but also reduce the activity of skin 5α-reductase, the enzyme...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics